Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Watson

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
NPJ Precision Oncology|October 17, 2025
Circulating enolase 1 as a diagnostic biomarker for early-stage breast cancerNikki Salmond, Renata Moravcova, Wing Sum Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancerSandra Troup, Catherine Njue, Erich V Kliewer, et al.
Biopreservation and Biobanking|June 14, 2019
Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018Victoria Hartman, Brent Gali, Simon Dee, et al.
Biopreservation and Biobanking|May 22, 2014
Permission to contact (PTC)--a strategy to enhance patient engagement in translational researchStefanie Cheah, Sheila O'Donoghue, Helena Daudt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Analysis of gene expression in ductal carcinoma in situ of the breastAdewale Adeyinka, Ethan Emberley, Yulian Niu, et al.
Breast Cancer : Basic and Clinical Research|June 23, 2011
Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)Nathan R West, Valerie Panet-Raymond, Pauline T Truong, et al.
Cancer Letters|January 13, 2009
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancerRonald Wolf, Christopher Voscopoulos, Jason Winston, et al.
Virchows Archiv : an International Journal of Pathology|April 24, 2009
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotypeAnne A Blanchard, George P Skliris, Peter H Watson, et al.
Breast Cancer Research and Treatment|December 24, 2008
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomasGeorge P Skliris, Brian G Rowan, Mariam Al-Dhaheri, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumorsGillian A Carleton, Sébastien Levesque, Lauren G Zacharias, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
NPJ Precision Oncology|October 17, 2025
Circulating enolase 1 as a diagnostic biomarker for early-stage breast cancerNikki Salmond, Renata Moravcova, Wing Sum Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancerSandra Troup, Catherine Njue, Erich V Kliewer, et al.
Biopreservation and Biobanking|June 14, 2019
Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018Victoria Hartman, Brent Gali, Simon Dee, et al.
Biopreservation and Biobanking|May 22, 2014
Permission to contact (PTC)--a strategy to enhance patient engagement in translational researchStefanie Cheah, Sheila O'Donoghue, Helena Daudt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Analysis of gene expression in ductal carcinoma in situ of the breastAdewale Adeyinka, Ethan Emberley, Yulian Niu, et al.
Breast Cancer : Basic and Clinical Research|June 23, 2011
Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR)Nathan R West, Valerie Panet-Raymond, Pauline T Truong, et al.
Cancer Letters|January 13, 2009
Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancerRonald Wolf, Christopher Voscopoulos, Jason Winston, et al.
Virchows Archiv : an International Journal of Pathology|April 24, 2009
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotypeAnne A Blanchard, George P Skliris, Peter H Watson, et al.
Breast Cancer Research and Treatment|December 24, 2008
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomasGeorge P Skliris, Brian G Rowan, Mariam Al-Dhaheri, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumorsGillian A Carleton, Sébastien Levesque, Lauren G Zacharias, et al.
Pageof 14